Non-steroidal anti-inflammatory drugs (NSAIDs) have been demonstrated to have significant cardiovascular and gastrointestinal toxicity; high dose of intake and concomitant use of multiple compounds or corticosteroids are factors that increase the risk of NSAID toxicity. In this paper we described our experience on NSAIDs misuse (both prescribing and OTC formulations), particularly relevant in the setting of rheumatoid arthritis (39.5% of patients) and osteoarthritis (47% of patients). We also evaluated causes underlying NSAIDs misuse (e.g, not satisfactory pain control, other painful conditions, etc).
Non-steroidal-anti-inflammatory drugs (NSAIDs) are commonly used for the treatment of chronic diseases such as osteoarthritis (OA) and rheumatoid arthritis (RA). These drugs have been demonstrated to have significant cardiovascular (l, 2) and gastrointestinal toxicity (3), in particular with high dose intake or concomitant use ofmultiple compounds (4) or corticosteroids (5) . NSAIDs are commercially available either as prescription-drug or over-thecounter (OTC) medications. OTC formulations contain lower dosages of the active principle as compared to the corresponding prescription drug, however, this does necessarily correlate with safer patient outcome (6) . From January 2012 to September 2012, a convenience sample of consecutive RA and OA patients being followed-up in our outpatient-clinic and for whom we had previously prescribed NSAID were evaluated for NSAID patterns of consumption.
Per clinic protocol, all patients are informed of the safety risks and precautions related to NSAID use. Five hundred forty-six RA and 508 OA were assessed. In all cases the NSAID prescribed in our clinic was taken correctly, according to our indications. In the 2 months preceding the visit, 216 RA patients (39.5%) concurrently took additional NSAIDs (over-users) and 147 (27%) were simultaneously on chronic corticosteroid treatment. Nimesulide (N= 90; 16%), acetyl-salicylic-acid (N=57; 10%) and OTC ibuprofen or diclofenac (N=105; 19%) were the most frequently associated NSAIDs. Incomplete pain control (N=105; 19%), headache (N=111; 20%), fever (N=51; 9%) and dental pain (N=24; 4%) were the predominant reasons for additional NSAID treatment as prescribed by other physician or self-administration. Neither gender (p=0.0834) nor mean age (p=0.2564) were different between NSAID over-user and non-over- Table  I characterized differences between RA and OA patients. Overall analysis reveals: a) NSAID overuse is common in both RA and OA; b) it involves both prescription and OTe drugs; and c) very importantly, conditions other than disease-related pain may lead to additional NSAID consumption as the result of physician prescription or self-medications. These findings indicate that physicians do not always take into account the pharmaceutical background of patients and patients are not completely aware of risks associated with NSAID use, despite having been previously informed, or perhaps are not familiar with other medications in the family ofNSAIDs. Based on these patterns of misuse revealed by this study and others (7) , clinicians must enhance their own habits of medication reconciliation in regard to multiple NSAIDs and concomitant glucocorticoid use as well as their approach to patient education in order to emphasize safe NSAID use and hopefully reduce the risk ofNSAID-re1ated side-effects.
